BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang H, Pan C, Zhang J, Zhu LL, Huang K, Zhong Y, Hu ZY. Olmesartan Reduces New-onset Atrial Fibrillation and Atrial Fibrillation Burden after Dual-chamber Pacemaker Implantation in Atrioventricular Block Patients. Chin Med J (Engl) 2016;129:2143-8. [PMID: 27625082 DOI: 10.4103/0366-6999.189924] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
Number Citing Articles
1 Proietti M, Romiti GF, Vitolo M, Borgi M, Rocco AD, Farcomeni A, Miyazawa K, Healey JS, Lane DA, Boriani G, Basili S, Lip GYH. Epidemiology of subclinical atrial fibrillation in patients with cardiac implantable electronic devices: A systematic review and meta-regression. Eur J Intern Med 2022:S0953-6205(22)00242-4. [PMID: 35817660 DOI: 10.1016/j.ejim.2022.06.023] [Reference Citation Analysis]
2 Costa MACD, Santos JFDLPD, Schafranski MD. Prevalence of Atrial Fibrillation in Pacemaker Patients. International Journal of Cardiovascular Sciences 2022. [DOI: 10.36660/ijcs.20200113] [Reference Citation Analysis]
3 Belkin MN, Soria CE, Waldo AL, Borleffs CJW, Hayes DL, Tung R, Singh JP, Upadhyay GA. Incidence and Clinical Significance of New-Onset Device-Detected Atrial Tachyarrhythmia: A Meta-Analysis. Circ Arrhythm Electrophysiol 2018;11. [DOI: 10.1161/circep.117.005393] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]